BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 27
• 28

• Drug Development

  NOXXON Pharma AG Initiates Phase IIa of Anti-Hepcidin Spiegelmer® NOX-H94

  December 4, 2012

   · 

  1 min read
• Business

  Cerus Corporation Signs Agreement With Swiss Red Cross for Initial Deployment of the INTERCEPT Blood System for Plasma

  December 4, 2012

   · 

  1 min read
• Genetown

  New Clinical Data Highlighting Foundation Medicine’s Next-Generation Sequencing Analysis in Breast Cancer to be Presented at SABCS

  December 4, 2012

   · 

  1 min read
• Business

  PhaseBio Pharmaceuticals, Inc. Positions for the Next Stage of Development by Bringing on Board Industry Veteran, Jonathan Mow as Chief Business Officer

  December 4, 2012

   · 

  1 min read
• Genetown

  Verastem, Inc. to Present at the 23rd Annual Oppenheimer Healthcare Conference

  December 4, 2012

   · 

  1 min read
• Axiogenesis Earns U.S. Patent With In Vitro Drug Discovery Assay for Hypertrophic Cardiomyopathy

  December 4, 2012

   · 

  1 min read
• Pharm Country

  Forest Laboratories, Inc. to Present Cariprazine Results From a Phase 3 Trial and Two Pharmacology Studies at the American College Neuropsychopharmacology (ACNP) Annual Meeting

  December 4, 2012

   · 

  1 min read
• Biotech Bay

  Gilead Sciences, Inc. to Present at the NASDAQ OMX 29th Investor Program

  December 4, 2012

   · 

  1 min read
• Biotech Bay

  Affymetrix (Santa Clara, California) Announces Redemption of 3.50% Senior Convertible Notes

  December 4, 2012

   · 

  1 min read
• Compugen Ltd. Presents at American Association of Cancer Research Special Conference on Tumor Immunology

  December 4, 2012

   · 

  1 min read